Tvashtr Biotech
Reimagining Foundation of Modern Diagnostics
We are building India's first Thermally field-stable, Modular, Electricity-free Molecular diagnostic diagnostic technology to empower doctors to treat patients at the point of care with rapid solutions, and help labs to enable testing at scale without the requirement of dependency on trained professionals
VISION
Health clarity is a hassle free right
Radically Accessible & Affordable Diagnostics
MISSION
IS MOLECULAR DIAGNOSTICS SCALED AT POINT OF CARE IN INDIA?
Dependency on Larger Testing facilities
90% of high-quality diagnostics are tied to centralised labs or hospitals.
Lack of adaptable technologies!
The unavailability of lab-accurate easy-to-use, rapid and portable devices.
Legacy Equipment Breakdown
Expensive and no switch options - Legacy devices cost ₹3–10 lakhs with high OPEX and service costs.
Testing limited to skilled staff to operate
Unaffordable/Expensive to scale at 1 million Units for Industries
AS INDIANS, DO WE TRULY UNDERSTAND ALLERGIES?
NO!
IF WE DO UNDERSTAND, WE WOULDN'T BE FACING THE ISSUES:
-
350M Indians suffer from allergies, but <5% ever get tested (Source: ICMR, ET Healthworld, 2022)
-
~90% of Hospitals, Clinics & Labs lack allergy testing capability; existing players (SRL, Metropolis, Lal Pathlabs) remain centralised & overpriced.
-
According to ICMR & ET Healthworld, Allergies are a recurring immune disorder that affects 20-30% of Indians, often worsening with repeated exposure, and require continuous testing, diagnosis, and monitoring.
-
This makes allergy diagnostics a long-term, underserved chronic space, just like thyroid and diabetes were in the 1990s.
Indian Landscape - Patient Use Cases
Tvashtr Biotech : Early, accessible testing → prevents escalation, saves lives, reduces costs
Elderly: Food, pollen & drug allergy delayed → hospitalization, 30% mortality in severe cases
Children: Dust allergy ignored → chronic asthma, lifelong inhaler dependence
Adult: Food allergy misdiagnosed → ER visit, fatal anaphylaxis risk, 30% productivity loss, absenteeism
Tvashtr Intervention
Interrupts at Stage 1 with early, accessible, accurate testing
Our Approach
It is key to understand that not just allergies but Diagnostics at Point of Care need an approach that solves not only technological but also frictional problems
1
Accessibiliy
Doctors want to treat the patient right away, and require tools that complement their diagnosis, so we provide them with smart tools.
2
Easy-to-Use
Handling at the Point of Care is tricky due to cold storage requirements, professional handling, result readout issues & clinical relevance, so we provide them with devices that are assistance proof
3
Post-test Support
Interpretation of results, with integrative AI for lifestyle support to help with food habits, body fitness and enabling direct control over health for users.
4
Whole-Body Wellness
Our approach blends diagnosis and lifestyle support to improve overall health and day-to-day life. During therapy, the in-house allergens can be utilised for desensitising the patient.
Rapid Allergy Testing Kit
Our Proposed Solution:
Note: Each dot represents an allergen (not yet labelled here). The blue dot means you have an allergy associated with that allergen. This is a representation of the diagnostic kit
.png)
-
Fully Autonomous & safely disposable, Handheld
-
Multiplex Biosensor Panel
-
Uses 2- 3 mL of Blood
-
Electronics-free device & Results in 30-40 Minutes
-
No professional assistance required
Camera Capture - Mobile AI-Based Severity Scoring
Website integrated cloud analysis → personalised insights + lifestyle support
Our Partners
SISFS Investor
Also incubated at
Research Partner
Academia Partner
Clinical Trials, Pilot & PI Partner Onboarding
.png){kind=logo}
SRM
